We are live on ! Find out more
FENC icon

Fennec Pharmaceuticals

105 hedge funds and large institutions have $175M invested in Fennec Pharmaceuticals in 2026 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 44 increasing their positions, 18 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 8

144% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 18

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

28% more capital inflows, than outflows

Capital inflows: $31M | Capital outflows: $24.3M

15% more funds holding

Funds holding: 91 → 105 (+14)

0.38% less ownership

Funds ownership: 47.15% → 46.77% (-0.38%)

Holders
105
Holders Change
+14
Holders Change %
+15.38%
% of All Funds
1.25%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
24
Increased
44
Reduced
18
Closed
8
Calls
$384​K
Puts
–
Net Calls
+$384​K
Net Calls Change
+$246​K

FENC Hedge Fund Activity: Q2 2026 in Review

105 of the 8,401 institutional investors tracked by Wall St. Rank reported a position in Fennec Pharmaceuticals (FENC) for Q2 2026, worth a combined $175M — up 76% from $100M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new FENC positions and 8 closed out — a net gain of 16 holders — while 44 added to existing stakes and 18 trimmed.

The largest buyer was AIGH Capital Management, adding an estimated $4.12M. The largest seller was Southpoint Capital Advisors, exiting entirely with an estimated $16.9M sold.

  • 105 institutional investors held Fennec Pharmaceuticals (FENC) as of Q2 2026, up from 91 in Q1 2026.
  • Funds reported $175M of Fennec Pharmaceuticals stock for Q2 2026, up 76% quarter-over-quarter.
  • 24 funds opened new Fennec Pharmaceuticals positions in Q2 2026 and 8 closed out, a net change of +16 holders.
  • The largest Fennec Pharmaceuticals buyer in Q2 2026 was AIGH Capital Management, an estimated $4.12M added.
  • The largest Fennec Pharmaceuticals seller in Q2 2026 was Southpoint Capital Advisors, an estimated $16.9M sold.

Based on aggregated 13F filings for Q2 2026.